Latest / Odessa News Today | 2 Min News | The Daily News Now!
mFlusiva mRNA Flu Shot Approved | Odessa News
FDA just approved a new mRNA flu vaccine for seniors called mFlusiva, made by Moderna — the same tech that revolutionized COVID vaccines. It’s poised to hit shelves soon, offering stronger protection for those 50+, especially vulnerable older adults. Clinical trials show it cuts flu cases by 27% in 50-64 year olds and shows strong immune response in those 65+. Mild side effects like soreness or fatigue were more common, but no serious safety issues. After an initial pause, FDA reversed course after Moderna’s push and independent panel endorsed approval — a major win for flu season…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.